Morpholine → HCID 178420827, compound
Reaction equation
[CH2:1]([C:4]1[C:13]2[O:12][C:11]([C:14]3[NH:18][N:17]=[N:16][N:15]=3)=[CH:10][C:9](=[O:19])[C:8]=2[C:7]([O:20][CH2:21][CH2:22][CH:23]([CH3:25])[CH3:24])=[CH:6][CH:5]=1)[CH:2]=[CH2:3].[NH:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1>O>[OH2:12].[NH:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1.[CH2:1]([C:4]1[C:13]2[O:12][C:11]([C:14]3[NH:15][N:16]=[N:17][N:18]=3)=[CH:10][C:9](=[O:19])[C:8]=2[C:7]([O:20][CH2:21][CH2:22][CH:23]([CH3:25])[CH3:24])=[CH:6][CH:5]=1)[CH:2]=[CH2:3]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
4.05 Parts of 5-[8-allyl-5-(3-methylbutoxy)-4-oxo-4H-1-benzopyran-2-yl]tetrazole and 1.03 parts of morpholine were mutually dissolved in 50 parts of water. The resulting solution was freeze-dried to give 4.8 parts of 5-[8-allyl-5-(3-methylbutoxy)-4-oxo-4H-1-benzopyran-2-yl]tetrazole morpholine salt monohydrate.
Workup
- customThe resulting solution was freeze-dried
Sources & evidence
- ORD record
- ord-1cfa047f19eb4a43807b9ba33c0644da
- Source dataset
- uspto-grants-1976_01
- Patent number
- US03933844
Reaction notes
Loading…